Hansol °Ç°­»ó´ã »çÀÌÆ®¸Ê
 
  :: ÇöÀçÀ§Ä¡ > Àλ縻
 
   
   
   
   
   
   
   
   
ÇѼֺ´¿ø¿¡¼­´Â 1999³â 3¿ùºÎÅÍ ¼ÒÈ­±â ³»°ú Àü¹®ÀÇ 4¸íÀ» ÃʺùÇÏ¿© Áø·á¸¦ °³½ÃÇÏ¿´½À´Ï´Ù.
ÇѼֺ´¿ø ³»°ú¿¡¼­´Â ´ëÀåÁúȯ(º¯ºñ, ¼³»ç, ¿°Áõ¼º Àå Áúȯ, ±Ë¾ç¼º ´ëÀå¿°, ´ëÀå¿ëÁ¾, ´ëÀå¾Ï,
°ú¹Î¼º ´ëÀå¿°), À§ÀåÁúȯ (¿ª·ù¼º ½Äµµ¿°, À§¿°, ¼ÒÈ­¼º ±Ë¾ç, À§¾Ï, Ç︮ÄÚ¹ÚÅÍ ÆÄÀ̷θ® °¨¿°Áõ),
°£Áúȯ (±Þ¸¸¼ºB,CÇü °£¿°, Áö¹æ°£, ¾ËÄڿüº °£Áúȯ, °£°æÈ­, °£¾Ï Á¶±âÁø´Ü), ´ã³¶, ÃéÀåÁúȯ
(´ã³¶ °á¼®, ´ã³¶¿°, ´ã³¶ Á¾¾ç, ÃéÀå¿°, ÃéÀå Á¾¾ç) µîÀÇ ¼ÒÈ­±â ÁúȯÀ» Àü¹®ÀûÀ¸·Î Áø·áÇϸç,
ÃÖ½ÅÀÇ ÀÇÇÐ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ¿¬±¸ ¹× Áø·á¸¦ ¼öÇàÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀüÀÚ ´ëÀå ³»½Ã°æ, ÀüÀÚÀ§
³»½Ã°æ, ¼ö¸é³»½Ã°æ, Ä®¶óµµÇ÷¯ÃÊÀ½ÆÄ µîÀÇ ÃֽŠ±â±¸¸¦ ±¸ºñÇÏ°í ¾çÁúÀÇ Áø·á¿¡ ´ëºñÇϰí ÀÖ½À´Ï´Ù.
- ¾à·Â ¼Ò°³ -
¿¬¼¼´ëÇб³ Àǰú´ëÇÐ Á¹¾÷
¿¬¼¼ÀÇ´ë ¿µµ¿¼¼ºê¶õ½º ¼ö·ÃÀÇ
¿¬¼¼ÀÇ´ë ¿µµ¿¼¼ºê¶õ½º Àü¹®ÀÇ
¿¬¼¼ÀÇ´ë ¿µµ¿¼¼ºê¶õ½º ÀüÀÓÀÇ
¿¬¼¼´ëÇб³ Àǰú´ëÇÐ ¿Ü·¡°­»ç

- ³í¹® -

1. ³»½Ã°æ À¯µÎ°ý¾à±Ù Àý°³¼ú°ú ūdz¼± À¯µÎÈ®Àå¼úÀ» º´¿ëÇÑ °Å´ë´ã°ü °á¼®ÀÇÄ¡·á(´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ)
2. °æÇǰ氣Àû ´ã³¶ ¹è¾×¼ú·Î ¿ÏÄ¡µÈ ±Þ¼º ±âÁ¾¼º ´ã³¶¿°(´ëÇѳ»°úÇÐȸ)
3. Soehendra ¹è¾×°ü Á¦°Å±â¸¦ ÀÌ¿ëÇÑ ¸¸¼º ÃéÀå¿°¿¡
ÀÇÇÑ Ãé°ü ÇùÂøÀÇ È®Àå¼ú(´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ)
4. ±Þ¼ºÃéÀå¿°ÀÇ Áø´Ü¿¡ À־ Urinary Trypsinogen-2 Dipsiticic °Ë»çÀÇ À¯¿ë¼º(´ëÇѼÒÈ­±âÇÐȸÁö)
5. À§°øÀå ¹®ÇպΠÇùÂø¿¡ À¯Ä¡µÈ ÀÚ°¡ÆØÃ¢Çü ±Ý¼Ó ½ºÅÙÆ®ÀÇ ½ÄµµÀÏÅ»(´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ)
6. Ư¹ß¼º ½Äµµ ¾ÆÄ®¶óÁö¾Æ ȯÀÚ¿¡¼­ÀÇ Ç÷û ½Å°æ¿ø Ç×ü ÃøÁ¤(´ëÇѼÒÈ­°ü¿îµ¿ÇÐȸÁö)
Ȳ¼ºÁØ
(ÀÇÇйڻç, ³»°ú Àü¹®ÀÇ)

- ¾à·Â ¼Ò°³ -
ÇѾç´ëÇб³ Àǰú´ëÇÐ Á¹¾÷
ÇѾç´ëÇб³ Àǰú´ëÇпø ÀÇÇйڻçÃëµæ
ÇѾç´ëÇб³ Àǰú´ëÇÐ ÀÎÅÏ,·¹Áö´øÆ® ¼ö·á
ÇѾç´ëÇб³ÀÇ·á¿ø ÀüÀÓÀÇ
ÇѾç´ëÇб³ÀÇ·á¿ø ÀÓ»ó°­»ç

- ³í¹® -
1. ¿ø¹ß¼º °£°áÇÙÀ¸·Î ÃßÁ¤µÈ À°¾ÆÁ¾¼º °£¿° 1¿¹ (´ëÇѳ»°úÇÐȸÁö)
2. Risk of advanced proximal adenoma and cancer according to rectosigmoid findings in the Korean population.(Dig Dis Sci.)
3.»óºÎÀ§Àå°ü ÃâÇ÷À» ÁÖ¼Ò·Î ³»¿øÇÑ À§°£ÁúÁ¾¾ç (´ëÇѳ»°úÇÐȸÁö)
4. ¸¸¼ºCÇü °£¿°È¯ÀÚ¿¡¼­ Pegylated interferon r-2aÄ¡·áÁß ¹ß»ýÇÑ Æóµ¶¼º 1¿¹(´ëÇѰ£ÇÐȸÁö 2007)
5 . SÀÚ°áÀå Á¤¸Æ·ù¸¦ µ¿¹ÝÇÑ Klippel-Trenaunay-Weber ÁõÈıº 1¿¹( ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸÁö)
6.¾Ç¼º ¿¡Å©¸° ÇѰøÁ¾ÀÇ ÆóÀüÀÌ 1¿¹(´ëÇѳ»°úÇÐȸÁö)
7.ÇÁ·ÎÇÊÆ¼¿ÀÀ¯¶ó½Ç (Propylthiouracil)°ú ¿¬°üµÈ p-ANCA ¾ç¼º Ç÷°ü¿°¿¡ µ¿¹ÝµÈ ÃÊÁ¡¼º ºÐÀý¼º »ç±¸Ã¼ °æÈ­Áõ 1¿¹(´ëÇѽÅÀåÇÐȸÁö)

¹ÚÀ±°æ
(³»°ú Àü¹®ÀÇ)

- ¾à·Â ¼Ò°³ -
Á¶¼±´ëÇб³ Àǰú´ëÇÐ Á¹¾÷
¼­¿ï¾Æ»êº´¿ø ³»°ú Àü¹®ÀÇ
¹Ì±¹ ÇÇÃ÷¹ö±× ´ëÇк´¿ø ÁßȯÀÚÀÇÇаú ¿¬¼ö
¼­¿ï¾Æ»êº´¿ø ¼ÒÈ­±â³»°ú ÀüÀÓÀÇ
°Ç±¹´ëÇб³º´¿ø ¼ÒÈ­±â³»°ú ÀÓ»ó°­»ç


¼ö»ó°æ·Â
2006³âµµ ´ëÇÑ À忬±¸ÇÐȸ Ãá°èÇмú´ëȸ

- ³í¹® -
1. Long-Term Outcome of Adefovir Dipivoxil Monotherapy in Patients with Lamivudine-Resistant Chronic Hepatitis B: 3-Year Follow-Up Data (¿ï»ê´ëÇб³´ëÇпø, 2007)
2. Mediastinal single nodal repalse of Nasal NK/T cell Lymphoma (The Korean Journal of Internal Medicine, 2007)
3.A case of peripancreatic castleman¡¯s disease which EUS-guided trucut biopsy has been useful in preoperative diagnosis (World Journal of Gastroenterology, 2008)

À̰æÈÆ
(³»°ú Àü¹®ÀÇ)
   

- ¾à·Â ¼Ò°³ -
¼øÃµÇâ´ëÇб³ Àǰú´ëÇÐ Á¹¾÷
¼øÃµÇâ´ëÇб³ Àǰú´ëÇÐ ÀÇÇаú ¹Ú»ç
¼øÃµÇâ´ëÇб³ ¼ÒÈ­±â³»°ú ÀüÀÓÀÇ
¼øÃµÇâ´ëÇб³ ¼ÒÈ­±â³»°ú Àü¹®ÀÇ, ÀÓ»ó±³¼ö
°æÈñ´ëÇб³ µ¿¼­½ÅÀÇÇк´¿ø ¼ÒÈ­±â³»°ú Àü¹®ÀÇ, ±³¼ö

¼ö»ó°æ·Â
2005³âµµ ¾Æ½Ã¾ÆÅÂÆò¾ç¼ÒÈ­±âº´ÁÖ°£Çмú´ëȸ plenary session ±¸¿¬ Áß Oral Presentation Award
2006³âµµ ÀÏÇѼÒÈ­±â³»½Ã°æ½ÉÆ÷Áö¿ò ¿ì¼öÆ÷½ºÅÍ»ó


- ³í¹® -
¿¬±¸½ÇÀû
Á¶±âÀ§¾Ï¿¡¼­ ³»½Ã°æ Á¡¸·ÇϹڸ®¼ú Á¶Á÷Ç¥º»ÀÇ ¸é¿ªÁ¶Á÷È­Çп°»ö¿¡ ´ëÇÑ ¿¬±¸(2008.08)
¼øÃµÇâ´ëÇб³ ³í¹®Áý

ĸ½¶³»½Ã°æ °Ë»çÀÇ Àüóġ·Î sodium phosphateÀÇ °æ±¸Åõ¿© È¿°ú (2005.08)
´ëÇѼÒÈ­±â³»½Ã°æÇÐȸÁö 2006;32:173-178

¾ç¼º ½Äµµ ÇùÂø¿¡¼­ÀÇ ÀϽÃÀû Àΰø°ü »ð°üÀÇ À¯¿ë¼º (2005.08)¼øÃµÇâ´ëÇб³³í¹®Áý

¿øÀÎ ºÒ¸íÀÇ À§Àå°ü ÃâÇ÷¿¡¼­ ĸ½¶³»½Ã°æ °Ë»çÀÇ À¯¿ë¼º(2005.08)´ëÇѼÒÈ­±â³»½Ã°æÇÐȸÁö

ÃéÀå µÎºÎ¾Ï È¯ÀÚ¿¡¼­ÀÇ Ãé°ü-°£¹®¸Æ ´©°ø 1¿¹ (2005.09)´ëÇѼÒÈ­±â³»½Ã°æÇÐȸÁö

º¯ºñÇü °ú¹Î¼º ÀåÁõÈıº°ú ±â´É¼º º¯ºñ ȯÀÚ¿¡¼­ Á÷Àå °¨°¢´ÉÀÇ Â÷ÀÌ(2005.07)´ëÇѼÒÈ­°ü¿îµ¿ÇÐȸÁö

ĸ½¶³»½Ã°æÀ¸·Î ¹ß°ßÇÑ ¼ÒÀåÃâÇ÷À» µ¿¹ÝÇÑ Henoch-Schonlein ÀÚ¹ÝÁõ 1¿¹(2004.06)
´ëÇѼÒÈ­±â³»½Ã°æÇÐȸÁö

»óÇà°áÀå¿¡¼­ ¹ß»ýÇÑ °ú¸³¼¼Æ÷ Á¾¾ç 1¿¹ (2003.05)
À忬±¸ÇÐȸÁö

Àϰú¼º ½É±Ù ÇãÇ÷°ú ´Ü¾È ½Ç¸íÀÌ µ¿¹ÝµÈ º£°Ô³ÊÀ°¾ÆÁ¾Áõ 1¿¹ (2003.03)´ëÇÑ·ù¸¶Æ¼½ºÇÐȸÁö

½ÉÀåÆó¼Ò»ý¼ú ÈÄ »ýÁ¸ÇÑ È¯Àڵ鿡¼­ÀÇ ±Þ¼º½ÅºÎÀüÀÇ ¹ß»ý°ú ÀÓ»ó°æ°ú.(2002.10)´ëÇѽÅÀåÇÐȸÁö

Æóµ¿¸Æ·ùÀÇ ¹ßÇöÀ¸·Î Áø´ÜµÈ ¿ëÀÇÇü º£Ã¼Æ®º´ 1·Ê
(2002.04)°áÇÙ¹×È£Èí±âÁúȯ2002;52(4):405-410

¿ø¹ß¼º ±¹ÇѼº ±â°ü±â°üÁöÇü À¯ÀüºÐÁõ 1¿¹ (2002.02)
°áÇÙ¹×È£Èí±âÁúȯ2002;52(2):74-178

¿¬±¸¹ßÇ¥
2006 ¹Ì±¹¼ÒÈ­±âº´ÁÖ°£(Digestive Disease Week)
The Role of Intraductal Ultrasound for Patients with Strictures in Intrapancreatic Portion of Distal Common Bile Duct at ERCP

2006 ¹Ì±¹¼ÒÈ­±âº´ÁÖ°£(Digestive Disease Week)
Training of Endoscopist Can Improve the Quality of On-site Determination for Cytological Adequacy in Endoscopic Ultrasound-Guided Fine Needle Aspiration.

2006 ¼¼°èÃÊÀ½ÆÄ³»½Ã°æÇÐȸ(15th international symposium on Endoscopic Ultrasonography)
Endoscopic Ultrasound-Guided Fine Needle Aspiration with On-site Determination of Cytological Adequacy by Endoscopists 2006 6 EUS 2006

2006 ¼¼°èÃÊÀ½ÆÄÇÐȸ(11th Congress of the World Federation for Ultrasound in Medicine and Biology)
Comparison between lymph nodes and pancreatic lesions in endoscopic ultrasound-guided fine needle aspiration with on-site
determination of cytological adequacy by endoscopicsts

2006 ÀÏÇѼÒÈ­±â³»½Ã°æ ½ÉÆ÷Áö¿ò
Training of Endoscopist Can Improve the Quality of On-site Determination for Cytological Adequacy in Endoscopic Ultrasound-Guided Fine Needle Aspiration.

2006 ¼ÒÈ­±â³»½Ã°æÇÐȸ Ãß°èÇмú´ëȸ
Èæ»öº¯À¸·Î ¹ßÇöµÈ ¼ÒÀåÀÇ ÇüÁú¸ð¼¼Æ÷¼º ¸²ÇÁÁ¾ 1¿¹

 

±èÇöÁ¤
(³»°ú Àü¹®ÀÇ)